GL1X · GenesisL1 explorer

Research workbench

PCSK9 in complex with compound 16

Analyse PCSK9 in complex with compound 16 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U26
Type
protein
Length
571 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proprotein convertase SUBTILISIN/KEXIN type 9
EC
3.4.21.-
UniProt
Q8NBP7
Ligands
063
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 19% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein9230% helix, 39% strandQ8NBP7
BProprotein convertase SUBTILISIN/KEXIN type 9 (EC 3.4.21.-)protein47917% helix, 38% strandQ8NBP7

Ligands and binding sites

  • 063 · 4'-{[(1R)-6-{2-[2-({N~5~-[N,N'-bis(tert-butoxycarbonyl)carbamimidoyl]-N~2~-(tert-butoxycarbonyl)-L-ornithyl}amino)ethoxy]ethoxy}-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2, 3,4-tetrahydroisoquinolin-7-yl]oxy}-2'-fluoro[1,1'-biphenyl]-4-carboxylic acid · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16480.740.8182063
23120.660.8246empty
31390.430.7525empty
4570.280.7413empty
5580.250.7215empty

Interfaces

1 interface between chains.

  • A–B · 1419 Ų buried · 27 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 disulfide (disulfide).

Compared structures

  • 6U26 · PCSK9 in complex with compound 16 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.